Lineage Cell Therapeutics Inc. (LCTX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Lineage Cell Therapeutics...

    AMEX: LCTX · Real-Time Price · USD
    1.67
    -0.05 (-2.91%)
    At close: Oct 03, 2025, 3:59 PM
    1.73
    3.59%
    After-hours: Oct 03, 2025, 07:25 PM EDT

    Lineage Cell Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 45.79M 35.44M 11.36M 55.74M
    Short-Term Investments
    		 2.02M 50K 46.52M 2.62M
    Long-Term Investments
    		 n/a 550K 581K 535K
    Other Long-Term Assets
    		 614K 27K 627K 630K
    Receivables
    		 638K 745K 297K 50.84M
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 2.55M 22.5K 1.83M n/a
    Total Current Assets
    		 51M 38.44M 60M 111.55M
    Property-Plant & Equipment
    		 4.39M 4.77M 5.67M 4.87M
    Goodwill & Intangibles
    		 57.21M 57.23M 57.36M 57.49M
    Total Long-Term Assets
    		 62.22M 62.58M 63.66M 63M
    Total Assets
    		 113.22M 101.02M 123.66M 174.54M
    Account Payables
    		 1.17M 2.05M 2.39M 3.54M
    Deferred Revenue
    		 7.39M 10.81M 9.42M 18.12M
    Short-Term Debt
    		 n/a n/a n/a 831K
    Other Current Liabilities
    		 n/a n/a 3.83M 21.63M
    Total Current Liabilities
    		 13.98M 17.96M 18.98M 47.12M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 6.16M 18.97M 2K 30K
    Total Long-Term Liabilities
    		 22.23M 21.04M 32.75M 36.53M
    Total Liabilities
    		 36.21M 39M 51.73M 83.65M
    Total Debt
    		 2.51M 2.95M 3.9M 2.8M
    Book Value
    		 77.01M 62.02M 71.94M 90.9M
    Book Value Per Share
    		 0.38 0.36 0.42 0.55
    Common Stock
    		 484.72M 451.34M 440.28M 434.53M
    Retained Earnings
    		 -403.46M -384.86M -363.37M -337.1M
    Comprehensive Income
    		 -2.88M -3.07M -3.57M -5.21M
    Shareholders Equity
    		 78.38M 63.42M 73.34M 92.22M
    Total Investments
    		 2.02M 50K 46.52M 2.62M

    Add to Watchlist